Integrated BioPharma, Inc. Aktie Other OTC
Aktien
120093
US45811V1052
INBP
Pharmazeutika
Umsatz 2022 | 56.25 Mio. 50.58 Mio. | Umsatz 2023 | 50.67 Mio. 45.57 Mio. | Marktwert | 9.92 Mio. 8.92 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2022 | 3 Mio. 2.7 Mio. | Nettoergebnis 2023 | - 0 | EV / Sales 2022 | 0.3 x |
Nettoschuld 2022 | 1.71 Mio. 1.54 Mio. | Nettoschuld 2023 | 1.36 Mio. 1.22 Mio. | EV / Sales 2023 | 0.22 x |
KGV 2022 |
4.17
x | KGV 2023 |
-292
x | Beschäftigte | - |
Rendite 2022 * |
-
| Rendite 2023 |
-
| Streubesitz | 20.22% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Riva Sheppard
CEO | Chief Executive Officer | 57 | 01.05.91 |
Christina Kay
CEO | Chief Executive Officer | 54 | 01.12.94 |
Dina Masi
DFI | Director of Finance/CFO | 63 | 17.11.05 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Christina Kay
CEO | Chief Executive Officer | 54 | 01.12.94 |
Damon Desantis
BRD | Director/Board Member | 56 | 20.06.22 |
Eric Friedman
BRD | Director/Board Member | 76 | 04.11.20 |
% 1. Jan. | Kap. | |
---|---|---|
+55.95% | 819 Mrd. | |
+43.27% | 638 Mrd. | |
-6.98% | 351 Mrd. | |
+19.08% | 329 Mrd. | |
+9.05% | 298 Mrd. | |
+17.09% | 242 Mrd. | |
+2.62% | 225 Mrd. | |
+13.18% | 217 Mrd. | |
+8.91% | 168 Mrd. |